Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the ...
Q4 2025 earnings call: record profits, 2026 margin expansion guidance, Nathan’s Famous deal and Sioux Falls capex—read key takeaways.
Former CFO Christina Ross discusses her transition to founder and CEO of Cube, raising capital, modernizing FP&A, and how the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results